Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Wellbutrin Stories

2012-10-09 07:27:32

AUSTIN, Texas, Oct. 9, 2012 /PRNewswire/ -- Edgemont Pharmaceuticals, LLC, a neuroscience-focused company, today announced that Forfivo(TM) XL (bupropion hydrochloride extended-release tablets) is now available nationwide for the treatment of major depressive disorder (MDD). Forfivo XL is the only extended-release bupropion HCl product to offer a once-daily, 450mg dose in a single tablet. (Photo - http://photos.prnewswire.com/prnh/20121009/NY88522 ) "Until now, most patients in the U.S....

Pharma Giant Agrees To Pay $3 Billion In Fines For Improper Practices
2012-07-02 19:08:05

Lawrence LeBlond for redOrbit.com - Your Universe Online Pharmaceutical giant GlaxoSmithKline (GSK) pleaded guilty and has agreed to pay the largest fine in US history over charges that it marketed drugs for unauthorized uses, held back safety data, and cheated the government´s Medicaid program, the US Justice Department (DOJ) announced Monday. GSK was also accused of paying kickbacks to doctors, funding expensive trips and other benefits, to gain their support for their drugs....

2012-07-02 06:25:14

PHILADELPHIA, July 2, 2012 /PRNewswire/ -- GlaxoSmithKline has just paid for one of the most expensive failed internal investigations in corporate history, qui tam whistleblower attorney Brian Kenney said today. His law firm, Kenny & McCafferty, P.C., represents the two whistleblowers who sparked the nine-year federal probe that ended with today's $3 billion payment to settle off-label drug marketing allegations involving nine prescription drugs. "When our clients were forced out of...

2006-12-18 09:01:25

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it has commercially shipped Bupropion Hydrochloride Extended-Release Tablets, 300 mg, the generic version of Biovail Corporation's antidepressant Wellbutrin XL® Tablets, pursuant to an agreement with IMPAX Laboratories, Inc. (NASDAQ:IPXL) and Anchen Pharmaceuticals, Inc. Wellbutrin XL® Tablets, 300 mg, marketed by GlaxoSmithKline, had U.S. sales of approximately $972 million for...

2006-03-23 00:35:00

By Karla Gale NEW YORK -- A new study shows that when patients with major depression fail to respond to a course of Celexa (citalopram) or cannot tolerate its side effects, approximately one third of those whose treatment is augmented with either bupropion (Wellbutrin) or Buspar (buspirone) will experience a remission of their depression. If they are instead switched to Wellbutrin, Zoloft (sertraline), or Effexor (venlafaxine), about one out of four will remit. These findings, based on two...

2006-02-10 14:15:00

NEW YORK (Reuters Health) - Supplementing the antidepressant Wellbutrin (bupropion) with a reward system called "contingency management" (CM) can further reduce cocaine use in addicted subjects maintained with methadone, new research shows. With CM, an addicted individual is given a positive reinforcement whenever he provides objective proof of a positive behavioral change. In the present study, subjects were given a small amount of money for each cocaine-free urine sample they provided. The...